Citigroup Downgrades Sotera Health to Neutral, Announces $9 Price Target
Citigroup analyst Patrick Donnelly downgrades Sotera Health (NASDAQ:SHC) from Buy to Neutral and announces $9 price target.
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 402 companies made new 52-week lows.
Keybanc Downgrades Sotera Health to Sector Weight
Keybanc analyst Matthew Mishan downgrades Sotera Health (NASDAQ:SHC) from Overweight to Sector Weight.
Needham Downgrades This Medical Equipment Stock Due To Lawsuit Risk
A Cook County jury awarded $363 million to a woman who developed breast cancer after living close to a medical…
Chemours, Alcoa And Other Big Losers From Wednesday
U.S. stocks closed lower with the Dow Jones dropping more than 500 points on Tuesday. Here is the list of some big stocks recording losses in the previous session.
Digital World Acquisition, Ford And Other Big Losers From Tuesday
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Tuesday. Here is the list of some big stocks recording losses in the previous session.
JP Morgan Downgrades Sotera Health to Underweight, Lowers Price Target to $9
JP Morgan analyst Tycho Peterson downgrades Sotera Health (NASDAQ:SHC) from Overweight to Underweight and lowers the price target from $26 to $9.
